血流感染诊断及治疗进展

[1] Four year prospective evaluation of nosocomial bacteremia: epidemilogy, microbiology, and patient outcome. Lark RL,Chenoweth C,Saints S,et al. Diagnostic Microbiology and Infectious Disease . 2 0 0 0

[2] Nosocomial bloodsteam infections: organisms,risk factors, and implications. Karchmer AW. Clinical Infectious Diseases . 2 0 0 0

[3] Bacteremia and antibiotic resistence of its pathogens reported in England and Wales between 1 9 9 0 and 1 9 9 8: trend analysis. Reacher MH,Shah A,Livermore DM,et al. British Medical Journal . 2 0 0 0

[4] Blood stream infections: microorganisms, risk factors and morality rate in Qutif central hospital. Ali ME,Abdul GM,Anil PK. Annals of Saudi Medicine . 1 9 9 8

[5] Antimicrobial resistence in key bloodstream isolates: electronic survellence with the Surveillance Network Database-USA. Sahm DF,Marsilio MK,Piazza G. Clinical Infectious Diseases . 1 9 9 9

[6] Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection in the USA, Canada and Latin American. Diekema DJ,Pfaller MA,Jones RN,et al. Int Marsilio MK, J Antimicrob Agents . 2 0 0 0

[7] Nosocomial bloodstream infection in United States hospital: a three-year analysis. Edmond MB,Wallace SE,McClish DK,et al. Clinical Infectious Diseases . 1 9 9 9

[8] Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1 9 9 7 in the United States, Canada, and Latin America from the SENTRY antimicrobial Surveillance Pro. Pfaller MA,Jones RN,Doern GV,et al. Diagnostic Microbiology and Infectious Disease . 1 9 9 9

[9] Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program ( United States and Canada, 1 9 9 7 ). Pfaller MA,Jones RN,Doern GV,et al. Antimicrobial Agents and Chemotherapy . 1 9 9 8

[1] Four year prospective evaluation of nosocomial bacteremia: epidemilogy, microbiology, and patient outcome. Lark RL,Chenoweth C,Saints S,et al. Diagnostic Microbiology and Infectious Disease . 2 0 0 0

[2] Nosocomial bloodsteam infections: organisms,risk factors, and implications. Karchmer AW. Clinical Infectious Diseases . 2 0 0 0

[3] Bacteremia and antibiotic resistence of its pathogens reported in England and Wales between 1 9 9 0 and 1 9 9 8: trend analysis. Reacher MH,Shah A,Livermore DM,et al. British Medical Journal . 2 0 0 0

[4] Blood stream infections: microorganisms, risk factors and morality rate in Qutif central hospital. Ali ME,Abdul GM,Anil PK. Annals of Saudi Medicine . 1 9 9 8

[5] Antimicrobial resistence in key bloodstream isolates: electronic survellence with the Surveillance Network Database-USA. Sahm DF,Marsilio MK,Piazza G. Clinical Infectious Diseases . 1 9 9 9

[6] Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection in the USA, Canada and Latin American. Diekema DJ,Pfaller MA,Jones RN,et al. Int Marsilio MK, J Antimicrob Agents . 2 0 0 0

[7] Nosocomial bloodstream infection in United States hospital: a three-year analysis. Edmond MB,Wallace SE,McClish DK,et al. Clinical Infectious Diseases . 1 9 9 9

[8] Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1 9 9 7 in the United States, Canada, and Latin America from the SENTRY antimicrobial Surveillance Pro. Pfaller MA,Jones RN,Doern GV,et al. Diagnostic Microbiology and Infectious Disease . 1 9 9 9

[9] Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program ( United States and Canada, 1 9 9 7 ). Pfaller MA,Jones RN,Doern GV,et al. Antimicrobial Agents and Chemotherapy . 1 9 9 8